TCL Archive In Brief: Potter Resigns As director Of Lombardi Cancer Center; Search Committee To Look for Successor July 24, 1987
TCL Archive FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug July 26, 2013
TCL Archive FOLFOX 4 Should Be First-Line Therapy For Advanced Disease, NCCTG Finds December 26, 2003
TCL Archive Cancer Funding To Defense Dept. Is Threat To National Cancer Program, Broder Says March 5, 1993